Supplementary Table S2 from Negative Hyperselection of Patients with HER2<sup>+</sup> and <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study
Randon G., Nakamura Y., Yaeger R., Lonardi S., Cremolini C., Elez E., Nichetti F., Ghelardi F., Nasca V., Bergamo F., Conca V., Ros J., Bando H., Maddalena G., Oldani S., Prisciandaro M., Raimondi A., Schrock AB., Agnelli L., Walch H., Yoshino T., Pietrantonio F.
<p>Response to dual HER2 blockade in patients with PRESSING-HER2 alterations.</p>